United-Power Pharma Tech Co., Ltd (UPP) is a bioanalytical focused CRO which provides high-quality pharmacokinetic, pharmacodynamic and immunogenicity evaluations for both biopharmaceutical and new chemical entities (NCE) in support of different stages of drug discovery and development programs.
UPP was founded in 2008 with our headquarters in Zhongguancun Life Science Park in Beijing. UPP has four test facilities in China with more than 15000-square-meter floor space to expedite our quality delivery. Thriving for scientific and quality excellence, we have proudly supported PK, PD and immunogenicity evaluation for more than six hundreds of discovery and development programs. We follow ISO/IEC17025 quality standards and the relevant regulatory guidance from NMPA, EMA, FDA and ICH. UPP had been accredited by CHINA NATIONAL ACCREDITATION SERVICE FOR CONFORMITY ASSESSMENT (CNAS) since 2017 for both biomolecule and small molecule bioanalysis. UPP has built strong collaboration with over 400 clients including many global pharmaceutical companies.